Overview

A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Subjects with Implanted Dual-Chamber Pacemakers or Defibrillators
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb